The PAF1 complex (PAF1C) is an evolutionarily conserved protein complex involved in transcriptional regulation and chromatin remodeling. How the PAF1C is involved in animal development is still not well understood. Here, we report that, in the nematode Caenorhabditis elegans, the PAF1C is involved in epidermal morphogenesis in late embryogenesis. From an RNAi screen we identified the C. elegans ortholog of a component of the PAF1C, CTR-9, as a gene whose depletion caused various defects during embryonic epidermal morphogenesis, including epidermal cell positioning, ventral enclosure and epidermal elongation. RNAi of orthologs of other four components of the PAF1C (PAFO-1, LEO-1, CDC-73 and RTFO-1) caused similar epidermal defects. In these embryos, whereas the number and cell fate determination of epidermal cells were apparently unaffected, their position and shape were severely disorganized. PAFO-1::mCherry, mCherry::LEO-1 and GFP::RTFO-1 driven by the authentic promoters were detected in the nuclei of a wide range of cells. Nuclear localization of GFP::RTFO-1 was independent of other PAF1C components, while PAFO-1::mCherry and mCherry::LEO-1 dependent on other components except RTFO-1. Epidermis-specific expression of mCherry::LEO-1 rescued embryonic lethality of the leo-1 deletion mutant. Thus, although the PAF1C is universally expressed in C. elegans embryos, its epidermal function is crucial for the viability of this animal.
Introduction
Temporally and spatially regulated gene transcription is essential during embryogenesis to produce diverse type of cells in a coordinated manner. For the tightly regulated transcription, recruitment of RNA polymerase II (Pol II) to the target genes and modulation of the Pol II activity is crucial. In addition, chromatin remodeling through alteration to nucleosomes by histone modification affects the DNA accessibility during transcription.
The Polymerase Associated Factor 1 (PAF1) complex, or PAF1C, is a protein complex conserved in eukaryotes, which is involved in multiple aspects of Pol II transcriptional regulation, including transcriptional elongation, 3 0 -terminal end processing, and histone modification (Jaehning, 2010; Tomson and Arndt, 2013) . This complex was originally identified in Saccharomyces cerevisiae as an RNA pol II interactor (Shi et al., 1996; Wade et al., 1996) , and consists of five proteins (Ctr9, Paf1/pancreatic differentiation 2, Leo1, Cdc73/parafibromin and Rtf1) (Mueller and Jaehning, 2002; Mueller et al., 2004) . None of the PAF1C components are essential for the viability of S. cerevisiae, but functional loss of the PAF1C causes diverse phenotypes including sensitivity to cellular stresses, which is linked to defects in chromatin and transcriptional regulation (Kim and Levin, 2011) .
Unlike in yeasts, the PAF1C in multicellular organisms are essential for viability, and implicated in a variety of developmental processes including the timing of flowering in plants (He et al., 2004; Oh et al., 2004) , and development of somite, heart, neuronal and craniofacial cartilage in zebrafish (Akanuma et al., 2007; Nguyen et al., 2010; Zhang et al., 2013a) . Additionally, the components of the PAF1C affect Hedgehog, Notch and Wnt signaling (Akanuma et al., 2007; Mosimann et al., 2006 Mosimann et al., , 2009 Tenney et al., 2006) . It also has been shown that the PAF1C regulates cell proliferation, cell differentiation, cell morphology, cell migration, maintenance of stem cells and tumorigenesis (Bai et al., 2010; Carpten et al., 2002; Ding et al., 2009; Langenbacher et al., 2011; Lin et al., 2008; Moniaux et al., 2006; Ponnusamy et al., 2009; Shi et al., 1996; Zhang et al., 2013b) . Although all five PAF1C components are conserved throughout eukaryotes, the human PAF1C contains another component Ski8/ Wdr61 that plays a role in mRNA decay (Zhu et al., 2005a) . In addition, Rtf1 in multicellular organisms is less tightly associated with other PAF1C components (Adelman et al., 2006; RozenblattRosen et al., 2005; Yart et al., 2005; Zhu et al., 2005a) . Thus, during the evolution of the PAF1C, alteration of the interaction within components and with other interactors may have led to expansion of the PAF1C function.
The nematode Caenorhabditis elegans provides an excellent system to study genetic control of dynamic cellular behaviors because of its highly reproducible development (Sulston et al., 1983) . The body elongation during C. elegans embryogenesis occurs through the coordinated shape change, migration and rearrangement of epidermal cells, in the absence of cell proliferation and cell death (Sulston et al., 1983) . During this process, cytoskeletons of epidermal cells are dynamically reorganized, and cell-to-cell adhesion and cell-to-ECM interaction are modified (Chin-Sang and Chisholm, 2000; Labouesse, 2012; Lynch and Hardin, 2009; Michaux et al., 2001; Simske and Hardin, 2001; Zhang and Labouesse, 2012) . However, gene regulations that control these dynamic behaviors of epidermal cells are still not well understood.
In this study, we identified an ortholog of the PAF1C components, Ctr9 (CTR-9) through an RNAi screen for genes involved in epidermal morphogenesis in late embryogenesis of C. elegans. We further identified other four orthologs of the PAF1C components (PAFO-1, LEO-1, CDC-73, and RTFO-1) and demonstrated that the PAF1C in C. elegans contributes to embryonic epidermal morphogenesis. This is the first functional analysis of the PAF1C in C. elegans, and will provide the bases for further studies on how this complex is involved in gene regulations in embryogenesis.
Materials and methods

C. elegans strains
C. elegans strains were derived from the wild-type Bristol strain N2 (Brenner, 1974) . Worms were grown at 24.5 1C, except for leo-1 (gk1081), which was maintained at 20 1C. The following alleles were used; unc-119(ed3), leo-1(gk1081) (C. elegans Gene Knockout Consortium), nT1[qIs51], xnIs17[dlg-1::GFPþ þrol-6(su1006)] (Firestein and Rongo, 2001; Totong et al., 2007) , tjIs57[pie-1p-mCherry::histone H2B þunc-119(þ)] (Toya et al., 2010), mcIs50[lin-26p:: vab-10 ABD::GFP, myo-2p::GFP, pBluescript] (Gally et al., 2009) , ruIs32[pAZ132::pie-1p:: GFP::histone H2B] (Praitis et al., 2001) , edIs20[neuronal promoter::GFP] (kindly provided by Dr. Joel Rothman), ccIs4251[myo-3p::GFP-LacZ (NLS), myo-3p::mitochondrial::GFP, dpy-20(þ)] (Kostas and Fire, 2002) , and mcIs46[dlg-1::RFPþ þunc-119(þ)] (Diogon et al., 2007) .
Transgenic worms were generated by microparticle bombardment transformation (for constructing integrated GFP/mCherry marker lines) (Praitis et al., 2001) or microinjection (for tissue specific rescue experiments) (Mello et al., 1991) , using unc-119(ed3) as the host strain. For transformation markers, Cbr-unc-119(þ) (Maduro and Pilgrim, 1996) , unc-119(þ) (pDP♯MM061B) (Maduro and Pilgrim, 1995) , or sur-5::GFP (pTG96) (Yochem et al., 1998) were used. The strains constructed in this study are listed in Supplementary Table S2 .
Homology analysis
The amino acid sequence comparison was performed using the protein-protein BLAST. The amino acid sequences of C. elegans CTR-9, PAFO-1, LEO-1, CDC-73 and RTFO-1 correspond to GeneBank entries NP_499090.1, NP_505925.1, NP_502135.1, NP_500465.3 and NP_505473.1, respectively. The amino acid sequences of H. sapiens hCtr9, hPaf1, hLeo1, hCdc73 and hRtf1 correspond to GeneBank entries NP_055448.2, NP_061961.2, NP_620147.1, NP_078805.3 and NP_055953.3, respectively.
Plasmid construction
The list of the plasmids constructed in this study is listed in Supplementary Table S3. For epidermal specific expression, we made a GATEWAY (Invitrogen) vector pYKN1R by substituting the pie-1 promoter and the pie-1 3 0 -UTR of pMTN1R (Toya et al., 2010) to the lin-26 promoter (Landmann et al., 2004) and the let-858 3 0 -UTR. The epidermal mCherry::TBB-2 expression plasmid (pYKN1R-tbb-2) was constructed by inserting the tbb-2 coding sequence into pYKN1R by LR reaction (Supplementary Table S3 ). To construct transgenes that express mCherry or GFP fusion proteins from authentic promoter, genomic fragments were PCR-amplified and fused with the mCherry/ GFP encoding DNA fragments. The details about the genomic fragments are described in Supplementary methods.
Tissue-specific rescue experiments
Transgenic worms were made by microinjection (Mello et al., 1991) using the following combination of plasmids: the mCherrytagged transgene (leo-1p::mCherry::leo-1, lin-26p::mCherry::leo-1, hlh-1p::mCherry::leo-1 or kal-1p::mCherry::leo-1), 5 μg/ml; an injection marker sur-5::GFP plasmid pTG96, 70 μg/ml; an unc-119(þ ) plasmid pDP♯MM016B (Maduro and Pilgrim, 1995) , 30 μg/ml; and pBluescript II KS(À ), 45 μg/ml. The extrachromosomal arrays of the resultant transgenic worms were transferred to unc-119(ed3);leo-1-(gk1081)/nT1[qIs51] animals by mating (Supplementary Table S2 ). To score embryonic lethality, embryos of the gk1081 homozygotes were obtained by dissecting the gonads, and after incubating for 24 h at 20 1C, arrested embryos among the SUR-5::GFP-positive progeny were scored.
Antibody production
The DNA fragment coding the N-terminal region (1-91 a.a.) of LEO-1 was PCR amplified from the cDNA clone yk1402b12 (kindly provided by Dr. Yuji Kohara) and cloned into an expression vector pColdI (Takara) containing the cspA promoter and 6xHis-tag. The 6xHis-LEO-1(91 a.a.) protein was expressed in E. coli BL21 (Invitrogen) at 15 1C, purified and used as the antigen. Affinity purified rabbit anti-LEO-1 antibody was generated by Medical and Biological Laboratories (Nagoya, Japan).
Western blot analysis for LEO-1
Young adult worms were placed on agar plates without bacteria to reduce bacterial contamination. Then, eight wild-type worms, eight leo-1(RNAi) worms and twenty leo-1(gk1081) worms were added to 15 μl each of 1Â sample buffer. The tubes were frozen and boiled for 5 min, then, the lysates were electrophoresed on a 4-15% gradient SDS-PAGE TGX gel (Bio-Rad). Rabbit anti-LEO-1 antibody (1:1000) and rabbit anti-histone H3 antibody (1:20,000, ab1791, Abcam) were used as primary antibodies. Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit antibody (1:50,000, Jackson) was used as secondary antibodies, and the signals were detected with chemilluminescence (Chemi-Lumi One Super Western blotting detection reagent, Nacalai Tesque). Signal was detected by ImageQuant 400 (GE Healthcare) and processed by Adobe Photoshop CS6 (Adobe).
RNAi
RNAi was carried out by the soaking method as described (Maeda et al., 2001) . dsRNA was prepared by in vitro transcription from cDNA clones (yk1575g06 for ctr-9/B0464.2, yk725d11 for pafo-1/C55A6.9, yk1402b12 for leo-1/B0035.11, yk1503c9 for cdc-73/F35F11.1, yk843e11 for rtfo-1/F25B3.6; all cDNA clones were gifts from Yuji Kohara). L4 worms were soaked in 2 mg/ml dsRNA soaking solutions and incubated at 24.5 1C for 24 h. The worms were then recovered and cultured at 24.5 1C. Phenotypes of the embryos were analyzed at 24 h after the recovery.
Microscopy
Fluorescence and Nomarski images of C. elegans embryos were acquired as described (Toya et al., 2011) . For time-lapse microscopy, embryos expressing fluorescently tagged proteins in Egg Buffer were mounted on 2% agarose pads. For each embryo, 15-60 Z-series images (0.5 μm steps or 1 μm steps) were acquired. The fluorescent Z-series images were projected using a maximum intensity algorithm of MetaMorph software (Molecular Devices) to produce a single integrated image. Images were processed with image J (NIH) or Adobe Photoshop CS6.
Time-lapse Nomarski microscopy was performed using Olympus BX63 microscope with iXon EM þ EM-CCD camera (ANDOR) and PlanApo N X60 oil NA1.42 objective lens. Fluorescence confocal microscopy was performed using the CSU-X1 spinning-disk confocal system (Yokogawa Electric Corp) mounted on Zeiss Axioplan2 microscope with iXon EM þ EM-CCD camera (ANDOR) and C-Apochromat X63 water NA1.2 objective lens. Images of nuclear localization of fluorescently tagged proteins were acquired using the CSU-X1 spinning-disk confocal system mounted on Olympus IX71 microscope with Orca-R2 12 bit/16 bit cooled CCD camera (Hamamatsu Photonics), UPlanSApo 60X silicone oil NA1.3 objective lens and UPlanSApo 100X NA1.4 objective lens. For imaging of actin and tubulin, the Olympus DSU (Disk Scanning Unit) system attached to Olympus BX61 microscope with PlanApo N 60X oil NA1.42 objective lens was used. All microscope systems were controlled by MetaMorph (Molecular Devices) software.
Results
The PAF1C is required for late embryogenesis of C. elegans
To identify genes involved in embryonic morphogenesis in C. elegans, an RNAi screen was performed. We previously identified $800 embryonic lethal genes by a large-scale RNAi analysis (Maeda et al., 2001 , and our unpublished data). The terminal RNAi phenotypes of these embryonic lethal genes were analyzed with the differential interference contrast (DIC) microscope and 60 of them showed late morphogenetic defects, such as limited elongation or body rupture. These genes were further analyzed by DIC live imaging, and the B0464.2 gene was identified as a gene that caused a reproducible body elongation defect at a high penetrance.
A homology analysis revealed that B0464.2 is a C. elegans ortholog of Ctr9 (hereafter, CTR-9), a component of the PAF1 complex (PAF1C) (Chu et al., 2013) (Table 1 ). The PAF1C is an evolutionarily well conserved protein complex, and consists of five components, Paf1, Ctr9, Leo1, Cdc73 and Rtf1 (Mueller and Jaehning, 2002; Mueller et al., 2004) . In addition to CTR-9, all other components of the PAF1C were identified in the C. elegans genome based on the sequence similarity (Paf1 ortholog C55A6.9/ PAFO-1, Leo1 ortholog B0035.11/LEO-1, Cdc73 ortholog F35F11.1/ CDC-73, and Rtf1 ortholog F25B3.6/RTFO-1) ( Table 1) .
To test whether the components of the C. elegans PAF1C work as a complex in late embryogenesis, RNAi phenotypes for each component were compared by the time-lapse DIC microscopy. Similar to the RNAi of the ctr-9 gene, RNAi knockdown of the four other genes caused morphogenesis defects in late embryogenesis (Fig. 1 , Table 1,  Supplementary Table S1 ). For all five genes, embryogenesis proceeded slower than the control embryos; eventually the embryos reached to morphogenesis stage, but their body elongation process was severely affected (Fig. 1, Supplementary Table S1 ). While the majority of ctr-9, pafo-1, leo-1, and rtfo-1 RNAi embryos exhibited aberrant body elongation (Fig. 1B-D and F) , $ 60% of the cdc-73(RNAi) arrested at earlier stage without significant body shape change (Fig. 1E , Supplementary Table S1 ). Thus, all five components of the PAF1C are essential for the progression of late embryogenesis. The slight differences of the morphogenesis phenotypes and penetrance imply that each component of the PAF1C may have distinct functions, either as a component of the PAFC or in addition to their role as a PAF1C component. It is also possible that the phenotypic differences were caused by the variable efficiency of RNAi, but at least for pafo-1, leo-1 and rtfo-1, RNAi reduced the corresponding proteins to the undetectable level (see below), thus partial RNAi effects were unlikely.
Loss of the PAF1C function does not reduce general gene expression
In other organisms, it has been shown that the PAF1C interacts with Pol II to modulate gene transcription (Jaehning, 2010; Tomson and Arndt, 2013) . To examine whether the late embryonic defects by RNAi knockdown of the PAF1C components were caused by general reduction of gene expression, expression of cell-type specific GFP markers were examined in these embryos. In all ctr-9(RNAi), pafo-1(RNAi), leo-1 (RNAi), cdc-73(RNAi) and rtfo-1(RNAi) embryos, the GFP signals of the cell type specific markers (neuronal marker, neuronal promoter::GFP; muscle marker, myo-3p::NLS::GFP; and epithelial marker, dlg-1p::DLG-1::GFP) were detected at the equivalent levels with the wild type ( Fig. 2A-F , and data not shown). Thus, the loss of the PAF1C component did not cause general reduction of gene expression, nor affect cell specification at least for neurons, muscles and epithelia.
The PAF1C is involved in positioning and shape change of epidermal cells
Since embryonic body elongation is driven by the epidermal cell shape change and migration, we examined the epidermal cell behaviors by live-imaging using a worm strain expressing an epithelial junction marker, DLG-1::GFP (Fig. 2E and F, Supplementary  Fig. S1 ). In the wild-type embryos, DLG-1::GFP-positive epidermal cells were formed dorsally, and they move ventrally to enclose the embryos. After enclosure, epidermal cells elongate in the anteriorposterior direction, which leads to the body elongation. In the ctr-9(RNAi), pafo-1(RNAi), leo-1(RNAi), cdc-73(RNAi) and rtfo-1(RNAi) embryos, position and cell shape of epidermal cells were aberrant during epidermal morphogenesis (Fig. 2F, Supplementary Fig. S1 ).
The severity and the timing of epidermal defects were variable. While most embryos showed defects in ventral enclosure of epidermal cells and epidermal elongation, some RNAi embryos showed leading cell movement to ventral midline. To further analyze the defects in epidermal cell patterning, nuclei of seam cells, the lateral subset of epidermal cells, were visualized with CEH-16::GFP (Cassata et al., 2005) . In the wild type, nuclei of ten seam cells are linearly aligned in each lateral side of embryos (Fig. 2G,  I , and K). In ctr-9(RNAi) embryos, the number of the seam cell nuclei was equivalent to the wild type (Fig. 2H, J, and K) . However, they are not linearly arranged from the onset of the morphogenesis stage (Fig. 2H) , and the cell misplacement became more severe in later stages (Fig. 2J) . Misplacement of epidermal cells was already evident at the time when the epidermal cells started expressing CEH-16::GFP or DLG-1::GFP, thus the cell positioning defect might have initiated before differentiation of epidermal cells.
These results suggest that the PAF1C does not affect epidermal cell proliferation and specification, but is required for cell shape change and positioning of epithelial cells.
CTR-9 is required for epidermal microtubule organization during morphogenesis
Actin and microtubule cytoskeletons are involved in epidermal cell shape change and migration in C. elegans embryogenesis (Diogon et al., 2007; Gally et al., 2009; Piekny et al., 2003; Priess and Hirsh, 1986; Williams-Masson et al., 1997 Wissmann et al., 1997) . To examine whether cytoskeleton in epithelial cells was affected in the RNAi embryos, we analyzed the actin and microtubule organization in epidermal cells by live-imaging during embryonic morphogenesis.
To visualize F-actin localization in epidermal cells, an actin marker VAB-10(ABD)::GFP was used (Gally et al., 2009) . During ventral enclosure, F-actin detected with VAB-10(ABD)::GFP was accumulated at the leading edge of the ventral epidermal cells (Patel et al., 2008) (Fig. 3A) . During the elongation stage, actin filaments in the dorsal and ventral epidermal cells were oriented circumferentially (Gally et al., 2009; Priess and Hirsh, 1986) (Fig. 3B) . Although the epidermal cell shape and migration were affected in the ctr-9(RNAi) embryos, VAB-10(ABD)::GFP accumulation at the leading edge during ventral closure and circumferential actin bundles in epidermal cells were detected ( Fig. 3C and D) .
Microtubules in epidermal cells during embryonic morphogenesis were visualized by mCherry::TBB-2 (β-tubulin) driven by the epidermal promoter, lin-26p (Landmann et al., 2004) . As reported previously, microtubules aligned circumferentially in dorsal and ventral epidermal cells in wild-type embryos at the elongation stage (Priess and Hirsh, 1986) (Fig. 3E) . In contrast, randomly oriented microtubules and aggregated mCherry::TBB-2 signals were often observed in ctr-9(RNAi) embryos during epidermal elongation process (Fig. 3F) .
These results imply that the loss of the PAF1C function affects the alignment of microtubules more severely than actin filaments in epidermal cells during the morphogenesis stage.
A deletion allele of leo-1 causes maternal effect embryonic lethality
To further analyze the requirement of the PAF1C in embryogenesis, a deletion allele for leo-1, gk1081, was used, which was isolated by the C. elegans Gene Knockout Consortium. The leo-1 locus encodes a predicted polypeptide of 430 amino acids, and the gk1081 allele deleted 627 bp that would result in a C-terminally truncated protein product of 137 amino acids (intrinsic 132 a.a. with extra 5 a.a.) (Fig. 4A) . A Western blot analysis using the anti-LEO-1 antibody raised against N-terminus of LEO-1 detected a 65 kDa band that migrated slower than the predicted molecular masse (48 kDa) in wild-type animals (Fig. 4B ). This band apparently corresponded to the LEO-1 protein because it was not detected in leo-1(RNAi) and the leo-1(gk1081) animals (Fig. 4B) . Slower mobility of Leo1 protein in SDS-PAGE was also reported for Leo1 orthologs in yeast and humans (Magdolen et al., 1994; Mueller and Jaehning, 2002; Rozenblatt-Rosen et al., 2005) . In the Western blot of the leo-1(gk1081) mutant extract, a weak 22 kDa band was detected, which was likely to correspond to the truncated LEO-1(gk1081) polypeptide (Fig. 4B) .
We found that leo-1(gk1081) mutant is maternal effect embryonic lethal. The gk1081 homozygotes from gk1081/þ heterozygotes were viable (embryonic lethality; 1.8%, n¼ 552) but showed partial sterility and defective vulvae (data not shown). The gk1081 homozygous progeny obtained by dissecting the gonads of these animals were mostly embryonic lethal with epidermal morphogenesis defects (82%, n ¼101) (Fig. 4D) , which is consistent with the phenotype of leo-1(RNAi) embryos. This maternal effect embryonic lethality was rescued by integrated transgenes tjIs279-[leo-1p::mCherry::leo-1] or tjIs308[leo-1p::GFP::leo-1] that contains the leo-1 genomic region with an in-frame mCherry or GFP insertion, confirming that this phenotype is caused by the loss of the LEO-1 function.
Epidermal expression of mCherry::LEO-1 rescues embryonic lethality of the leo-1(gk1081) mutant
As mentioned above, tjIs279[leo-1p::mCherry::leo-1] transgenes (Fig. 4A ) rescued embryonic lethality of leo-1(gk1081) homozygous animals, thus, the fusion proteins were regarded functional and their expression pattern was expected to reflect that of the endogenous LEO-1. In embryos that have tjIs279[leo-1p::mCherry:: leo-1], mCherry::LEO-1 was detected in the nuclei of virtually all cells throughout embryogenesis from the one-cell stage (Figs. 5B and 6B).
Since leo-1(RNAi) and leo-1(gk1081) both exhibited defects in epidermal morphogenesis, we next asked whether expression of LEO-1 in epidermal cells was sufficient to rescue the mutant phenotype. The mCherry::leo-1 coding fragment was expressed under promoters that drive expression in specific cell types (epidermal promoter, lin-26p; neuronal precursor promoter, kal-1p; and muscle promoter, hlh-1p). Expression of mCherry::LEO-1 under the control of the epidermal promoter (lin-26p) rescued the leo-1(gk1081) lethality, as efficient as the authentic leo-1 promoter (Fig. 4C) . On the other hand, expression of mCherry::LEO-1 under the muscle promoter or the neuronal promoter did not rescue embryonic lethality (Fig. 4C) . Thus, although LEO-1 is expressed in a wide range of cells during embryogenesis, its expression in epidermal cells is crucial for the viability of the animal.
Components of the PAF1C localize to the nuclei of a wide range of cells during embryogenesis
In addition to LEO-1, expression patterns of PAFO-1 and RTFO-1 were analyzed by constructing transgenic insertion strains in which PAFO-1::mCherry or GFP::RTFO-1 were expressed under the control of authentic promoters. Similar to LEO-1, PAFO-1:: mCherry was detected in the nuclei of virtually all embryonic cells from the one-cell stage (Fig. 5A , and data not shown). GFP::RTFO-1 was also detected in nuclei of a wide range of cells but only after $30-cell stage and except for germ cells (Fig. 5C , and data not shown). Thus, these three components of the PAF1C were coexpressed in the majority of somatic cells during embryogenesis.
Subnuclear localization of PAFO-1::mCherry, mCherry::LEO-1 and GFP::RTFO-1 were examined using GFP::histone H2B or mCherry::histone H2B as a comparison. PAFO-1::mCherry, mCherry::LEO-1 and GFP::RTFO-1 were not uniformly present within the nuclei, but enriched in discrete nuclear regions (Fig. 5A-C) . Notably, these proteins were only partially colocalized with histone signals within the nuclei (Fig. 5A-C) . A larger fraction was colocalized within the nuclei for the combinations [GFP::LEO-1 and PAFO-1::mCherry] and [GFP::RTFO-1 and PAFO-1::mCherry], whereas GFP::RTFO-1 appeared more uniformly distributed in the nuclei than PAFO-1::mCherry ( Fig. 5D and E) .
To analyze the cell cycle-dependent change of the localization of the PAF1C, mCherry::LEO-1 was observed by live-imaging of 1-cell stage embryos, in which the nuclear size is much larger than late embryos and localization change can be readily observed. Before mitosis, the intense mCherry::LEO-1 signal was detected within the nuclei. Upon mitotic nuclear envelope breakdown (NEBD), the nuclear mCherry::LEO-1 signal apparently diffused within the cytoplasm (Fig. 5F ). During metaphase through anaphase, mCherry::LEO-1 was not detected on condensed chromosomes. In telophase when nuclear envelope is reassembled, mCherry::LEO-1 signal became detectable again in the nuclei (Fig. 5F ). These results suggest that the vast majority of LEO-1 is not tightly associated with chromatins, and it is actively transported to the nucleus from the cytoplasm.
Interdependency of the nuclear localization of the PAF1C components
In yeast, it has been shown that the overexpression or depletion of each component of the PAF1C can influence the level of other (bottom) in the control (E) and ctr-9(RNAi) (F) embryos at comma stage. Magnified images of the boxed areas are shown in the right panels. Scale bar: 10 μm.
components (Mueller et al., 2004; Shi et al., 1997) . Therefore, we asked whether the depletion of each PAF1C component affect the protein level or subcellular localization of other components in C. elegans. The subcellular localization of PAFO-1::mCherry, mCherry:: LEO-1 and GFP::RTFO-1 were analyzed in embryos in which one of the components of the PAF1C was depleted by RNAi (Fig. 6) . In pafo-1(RNAi), leo-1(RNAi) and rtfo-1(RNAi) embryos, corresponding fluorescently tagged proteins (PAFO-1::mCherry, mCherry::LEO-1 and GFP::RTFO-1, respectively) became undetectable, confirming the efficiency of RNAi depletion (Fig. 6G, K, and R) .
In ctr-9(RNAi) and leo-1(RNAi) embryos, nuclear PAFO-1:: mCherry was significantly decreased and while cytoplasmic fraction increased (Fig. 6D and J) . In cdc-73(RNAi) embryos, PAFO-1::mCherry was evenly detected in cytoplasm and nuclei (Fig. 6M) . In contrast, in rtfo-1(RNAi) embryos, nuclear localization of PAFO-1::mCherry was unaffected (Fig. 6P) . Similarly, in ctr-9(RNAi) and pafo-1(RNAi) embryos, mCherry::LEO-1 was mainly detected in the cytoplasm, but not in the nuclei (Fig. 6E and H) . In cdc-73(RNAi) embryos, nuclear mCherry:: LEO-1 was decreased and it was detected evenly both in cytoplasm and nuclei (Fig. 6N) . As seen for PAFO-1::mCherry, the nuclear localization of mCherry::LEO-1 was unaffected in rtfo-1(RNAi) embryos (Fig. 6Q) . These results suggest that PAFO-1 and LEO-1 localize to the nuclei independently of RTFO-1, but dependent on other three components.
Unlike mCherry::LEO-1 and PAFO-1::Cherry, nuclear localization of GFP::RTFO-1 was unaffected in leo-1(RNAi), pafo-1(RNAi), ctr-9(RNAi) and cdc-73(RNAi) embryos (Fig. 6F, I , L, and O). These results suggest that RTFO-1 localizes in nuclei independently of other components of the PAF1C.
Taken together, we speculate that four components of the PAF1C except RTFO-1 form a subcomplex to be transported to nuclei in an interdependent manner; on the other hand, RTFO-1 can localize to nuclei independently of other components (Fig. 6S ).
Discussion
The PAF1C is an evolutionarily conserved protein complex that consists of Paf1, Ctr9, Rtf1, Cdc73 and Leo1 (Mueller and Jaehning, 2002; Mueller et al., 2004) . The studies mainly in yeasts and mammalian culture cells demonstrated that the PAF1C is involved in multiple aspects of RNA pol II transcriptional regulation and histone modifications (Jaehning, 2010; Tomson and Arndt, 2013) . Whereas the PAF1C is dispensable for yeast (Chang et al., 1999; Porter et al., 2002; Shi et al., 1996 Shi et al., , 1997 , recent studies revealed that it is required in diverse biological processes including stem cell pluripotency, cell cycle regulation, and development (Ding et al., 2009; Mosimann et al., 2009; Ponnusamy et al., 2009; Porter et al., 2002; Tenney et al., 2006) . In this study, we performed the first functional analysis of the PAF1C in the development of C. elegans, and demonstrated its requirement in various processes of epidermal morphogenesis, including epidermal cell positioning, ventral enclosure and epidermal elongation.
While components of the PAF1C were present in the majority of cells throughout C. elegans embryogenesis, its expression in epidermal cells was crucial for the viability of this animal. While epidermal cell fate determination was not apparently inhibited by the loss of the PAF1C components, circumferentially oriented microtubules in the dorsal and ventral epidermal cells during epidermal morphogenesis (Priess and Hirsh, 1986) were disorganized in ctr-9(RNAi) embryos. Thus, one possibility of the role of the PAF1C might be modulating expression of microtubule regulators by controlling RNA pol II transcription or by affecting histone modifications. It remains unclear whether the microtubule defects at elongation stage are causative or a result of earlier defects in epidermal cell positioning.
We showed in C. elegans late embryos that PAFO-1, LEO-1 and RTFO-1 tagged with GFP or mCherry were unevenly localized in the nuclei of a wide range of cells. This finding is consistent with the report in other organisms that the PAF1C localizes at transcriptionally active chromatin loci (Adelman et al., 2006; Chen et al., 2009; Kim et al., 2010; Rozenblatt-Rosen et al., 2009 ). For example, in Drosophila salivary glands, Paf1 and Rtf1 are colocalized with RNA pol II at actively transcribed loci on chromatins (Adelman et al., 2006) . On the other hand, the vast majority of nuclear PAF1C were not tightly associated with chromatins at least in early C. elegans embryos, which may correlate to the fact that transcription is globally repressed in early C. elegans embryos (Edgar et al., 1994) .
The nuclear localization of PAFO-1 and LEO-1 was dependent on other PAF1C components except RTFO-1. On the other hand, RTFO-1 localized to nuclei independently of other PAF1C components. In addition, whereas PAFO-1 and LEO-1 were expressed in virtually all cells from the 1-cell stage, RTFO-1 was not expressed before $ 30 cells and in germline cells. Thus, RTFO-1 and other four components apparently behave differently during embryogenesis. We speculate that nuclear localization of PAFO-1, LEO-1, CTR-9 and CDC-73 are interdependent, probably by forming a subcomplex. CDC-73 contains a nuclear localization signal that is conserved in Cdc73 orthologs in other organisms (Bradley et al., 2007; Hahn and Marsh, 2005) , which may contribute to the nuclear localization of the potential subcomplex. RTFO-1 is likely to be independently transported to nuclei, then forms the complete PAF1C by associating with the subcomplex, which promotes epidermal morphogenesis in C. elegans.
Our observations of the distinct behavior of RTFO-1 from other four PAF1C components are consistent with the findings in other organisms (Adelman et al., 2006; Kim et al., 2010; Langenbacher et al., 2011; Rozenblatt-Rosen et al., 2005) . In Drosophila, recruitment of Paf1 and Rtf1 to transcriptionally activated Hsp70 loci is independently controlled (Adelman et al., 2006) . Biochemical analysis showed that hRtf1 was not included in the same fraction as that of hCdc73/hPaf1 in human cells (Rozenblatt-Rosen et al., 2005) . Furthermore, in human cells, it was reported that some PAF1 complexes contain hSki8 instead of hRtf1 (Ponnusamy et al., 2009; Zhu et al., 2005b) . Thus, in some C. elegans cells, such as the early embryonic cells before $ 30 cell stage or in germline cells in which RTFO-1 is undetected, it is plausible the PAF1 subcomplex composed of PAFO-1, LEO-1, CTF-9 and CDC73 may function independently of RTFO-1, possibly by associating other factor(s).
Our study also demonstrated that the loss of each component of the PAF1C caused similar epidermal morphogenesis phenotypes, but their severity and penetrance were different for each gene. Interestingly, differential phenotypes by the loss of the each PAFC component have also been reported in zebrafish in which the PAF1C is involved in cardiac specification and heart morphogenesis (Nguyen et al., 2010) . Phenotypes caused by the knockdown of individual component of the PAF1C were overlapping but distinct, and loss of Rtf1 function resulted in the most severe defects in the specification of cardiac precursors (Langenbacher et al., 2011) . Our results and the report in zebrafish raise the possibility that, while all PAF1C components are required for the PAF1C function, each component may have distinct roles in regulating gene expression, possibly by affecting the stability of the complex or specific protein-protein/ protein-DNA/RNA interactions. Alternatively, these proteins may have additional function(s) unrelated to the PAF1C. Further studies on the role of each component and that of the PAF1C as a whole will be needed to understand how these proteins participate in the regulation of gene expression during development.
